ArticleFrontiers in endocrinology2026
Secreted frizzled-related protein 3 is associated with metabolic disturbances in gestational diabetes.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aims: Secreted modulators of the Wingless (WNT) pathways are associated with cardiometabolic dysregulation. Among these, Dickkopf-1 (DKK1) and secreted frizzled-related protein-3 (sFRP3) are abundantly expressed in placental tissue and secreted into the maternal circulation. We hypothesized their plasma levels would be dysregulated in women with gestational diabetes mellitus (GDM) and correlate with indices of metabolic health. Methods: A total of 284 women during pregnancy and at 5 years postpartum participated in this longitudinal cohort study. Secreted Wnt modulators were analyzed by enzyme immunoassay 4 times during pregnancy and postpartum. Lipids and indices of glucose tolerance were assessed twice in pregnancy and at follow-up. Body composition and pulse wave velocity analysis was assessed at follow-up. Results: Our main findings: i) plasma DKK1 was lower throughout pregnancy in women with GDM. ii) sFRP3 was lower early in pregnancy in women with GDM and correlated with indices of obesity and adipose tissue related inflammation, insulin resistance, poor β-cell function and unfavorable lipid ratios. iii) low DKK1 during pregnancy was associated with higher aortic stiffness at follow-up. Conclusions: Low plasma sFRP3 during early pregnancy is associated with metabolic and inflammatory dysregulation while persistently low DKK1 may be associated with future cardiovascular disease risk in GDM pregnancies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.